Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis

Steven Flamm*, David Mutimer, Armen Asatryan, Stanley Wang, Jürgen Rockstroh, Yves Horsmans, Paul Y. Kwo, Ola Weiland, Erica Villa, Jeong Heo, Edward Gane, Stephen D. Ryder, Tania M. Welzel, Peter J. Ruane, Kosh Agarwal, Teresa I. Ng, Zhenyi Xue, Sandra S. Lovell, Preethi Krishnan, Sarah Kopecky-BrombergRoger Trinh, Federico J. Mensa, David L. Wyles

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences